Dear Colleagues,
Greetings to everyone. I have enjoyed seeing many of our extramural community at various conferences over the last few months, and am pleased that so many of you are continuing to push forward in doing outstanding research, writing grants, mentoring junior members of the discipline, and keeping your chin up during trying times. Back here in the NCI Behavioral Research Program, we are continuing to work hard to fund terrific science, provide data and tools to the extramural community, and be a source of support. We are open for business and continue to aim toward our mission of ending cancer as we know it.
I have had the privilege of leading BRP since 2009 and will soon be departing federal service to take on a new leadership role – I have been appointed Dean and Distinguished Professor in the School of Communication and Information at Rutgers University. I will greatly miss my colleagues and the noble mission here at NIH. Fortunately, I know that BRP will be in good hands as I pass the torch to Dr. Paige Green, currently the chief of the Basic Biobehavioral and Psychological Sciences Branch within BRP, who becomes Acting Associate Director on June 1. With over 25 years of dedicated service, Dr. Green has built deep institutional knowledge and forged strong interpersonal connections, contributing to multiple NCI and division leadership communities, championing numerous scientific initiatives, and maintaining a grant portfolio and mentorship duties.
Dr. Green’s impact extends beyond NCI. She has been recognized as an elected Fellow and Secretary of the Academy of Behavioral Medicine Research, where she received the Outstanding Lifetime Service Award, and Past President and elected Fellow of the Society for Biopsychosocial Science and Medicine (formerly the American Psychosomatic Society). She has contributed extensively to the research community as an editorial board member, guest editor, and reviewer for leading peer-reviewed journals. Dr. Green is a trained clinical psychologist with a research emphasis on behavioral medicine and psychophysiology within the context of chronic disease and health psychology.
Most importantly, Dr. Green holds unwavering commitment to rigorous science and the people who make it possible. I know she will lead with integrity, purpose, and a deep dedication to our shared mission in conducting and supporting research to lessen the burden of cancer, reduce incidence, and improve survival and quality of life.
In this issue, we include expiring funding opportunities, administrative supplement policies, Highlighted Topics, resources, and scientific advances from staff and grantees.
You can always find data resources and upcoming events on our website.
We appreciate your feedback, and as a reminder, you may manage your BRP newsletter subscription at any time. We hope you find the information beneficial.
All the best,
Bill Klein
Associate Director (09/2009 – 06/2026)
Funding Notices
Expiring Funding Opportunities
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development
PAR-25-170 (UG3/UH3 Clinical Trial Optional)
NCI Contact: Dana Wolff-Hughes
Posted: November 13, 2024
Close Date: June 22, 2026
Tobacco Regulatory Science Small Grant Program for New Investigators
RFA-OD-25-008 (R03 Clinical Trial Optional)
NCI Contact: Maria Roditis
Posted: June 24, 2025
Close Date: July 14, 2026
Cancer Prevention and Control Clinical Trials Grant Program
PAR-25-167 (R01 Clinical Trial Required)
NCI Contact: Tanya Agurs-Collins
Posted: November 12, 2024
Close Date: January 07, 2027
Population Approaches to Reducing Alcohol-related Cancer Risk
PAR-25-221 (R01 Clinical Trial Optional)
NCI Contacts: Heather D’Angelo and Kirsten Herrick
Posted: November 06, 2024
Close Date: January 07, 2027
Administrative Supplements in Cancer Control
NIH policy allows for administrative supplements within the scope of the peer-reviewed and approved project to support costs and activities unforeseen at the time of the parent grant award. Supplements must be within scope of the parent award and must comply with all limitations on administrative supplements. Further instructions are on the NIH Administrative Supplements website. Please contact your program director or the topic lead as you have ideas. We look forward to connecting with you.
Applications will be accepted through July 31, 2026. Applicants are encouraged to apply early, as submissions will be reviewed and funded on a rolling basis.
NIH Collaborative International Research Project (PF5)
NIH no longer accepts applications that request funds for foreign components using the traditional grant subaward/consortium structure. The PF5 activity code facilitates an application and award structure that allows NIH to track the expenditure of federal funds at foreign components and meet federal reporting and oversight needs.
View this video on an Introduction to the NIH Collaborative International Research Project (PF5) Application and Award Structure.
NIH Highlighted Topics
NIH continues to release highlighted topics for investigator-initiated grant application, representing priority areas within one or more NIH Institutes, Centers, or Offices. NIH recently published several cancer-related topics:
- GLP-1s: Implications for nutritional status and metabolic health outcomes
- Advancing nutrition research to inform regulatory practice
- Training and career development in dissemination and implementation science
- Research on rare cancers across the cancer control continuum
- Optimal interprofessional teaming and care coordination strategies for cancer care quality and outcomes
- Advancing mechanism-driven translational research of beneficial and detrimental effect of psilocybin on cancer and other health conditions
- Advancing childhood and adolescent & young adult (AYA) cancer research
- Enhancing scientific rigor, transparency and replicability
If any of these (or other Highlighted Topics) align with your research interests, we encourage you to reach out early to the appropriate scientific contacts. Program staff can help you determine how your research idea may fit, identify appropriate parent funding opportunities, and answer questions related to your application.
Resources
Adolescent Brain Cognitive DevelopmentSM (ABCD) Study Data Release
The ABCD Study® is the largest longitudinal study of brain development and child health in the United States. The ABCD 7.0 Data Release includes cumulative data from the full participant cohort through the 5-year follow-up visit and nearly the entire cohort at the 6- and 7-year follow-up visits. The ABCD 7.0 data release also contains whole-genome sequencing data for approximately 80% of the cohort, longitudinal linked external data, as well as data from associated substudies, including Social Development, COVID-19, and the newly added Baby Teeth, RECOVER, and Structured Interview for Psychosis-Risk Syndromes. Learn more about the ABCD 7.0 Data Release.
HINTS Controlled Access Datasets Now Open
The Health Information National Trends Survey (HINTS) Management Team has announced controlled access datasets are now available for request through the National Library of Medicine’s database of Genotypes and Phenotypes (dbGaP) system. Controlled access datasets include HINTS-SEER (2021), HINTS Data Linkage Projects (2020, 2022, and 2024), and the geo-coded versions of HINTS 4 Cycle 1 (2011) through HINTS 5 Cycle 3 (2019), which include more granular geo-codes and certain suppressed variables not available in the public-use version of these datasets. Discover HINTS controlled access datasets.
HINTS Brief 59: Awareness and Perceived Value of Multi-Cancer Early Detection Tests Among US Adults
The HINTS Brief 59, “Awareness and Perceived Value of Multi-Cancer Early Detection Tests Among US Adults,” examines the public’s familiarity with, and perceptions about, multi-cancer early detection (MCED) tests. View HINTS Brief 59. View HINTS Brief page.
New SEER Data Available: Updated Statistics and Analytical Tools
New Surveillance, Epidemiology, and End Results (SEER) data has been released with updated cancer incidence, survival, and prevalence statistics. This includes data from the November 2025 submission, incidence data from 1975-2023, US mortality data through 2024, and updated resources on the Surveillance Research Program website, including a new version of DevCan, and updated delay-adjustment methodology documentation. Access SEER*Stat. Access SEER*Explorer.
NIH Brain Development Cohorts (NBDC) Data Hub
ABCD (and HEALthy Brain and Child Development, or HBCD) Study data are available through the NIH Brain Development Cohorts (NBDC) Data Hub, a secure data management and analysis platform offering:
- Scalable integration of large, multimodal datasets, including neuroimaging, EEG, and genomics data
- Customized query tools and data ontologies to identify variables of interest
- Compute-in-place Sandbox with standard tools (RStudio, Jupyter Notebooks, Linux desktop)
- New! Compute-in-place Data Exploration & Analysis Portal (DEAP), a graphical user interface for dataset creation, visualization, and analysis of tabulated data as well as voxel- and vertex-wise (and soon connectome-wise) imaging data for ABCD data. Access DEAP documentation.
Morbidity and Mortality Weekly Report (MMWR) on the Prevalence and Context of Sunburn Among US Adults – United States, 2024
New MMWR reports over 88 million adults experience at least one sunburn each year in the United States and almost 19 million experience 4 or more sunburns. Sunburn increases the risk of skin cancer, the most common cancer in the US Even one sunburn at any age increases risk, with more sunburns leading to a greater risk of skin cancer. Read more on the prevalence of sunburn among US adults.
Selected Scientific Advances
Meng X, Eulalio T, Oh K, et al. Cancer treatment-related cardiotoxicity among survivors of childhood cancer: a comparative and integrated view of multiple measures of biological age acceleration. Cancer Epidemiol Biomarkers Prev. Published online April 19, 2026. doi:10.1158/1055-9965.EPI-25-1472
Shreves AH, Maylor B, Hyde ET, et al. Step counts and stepping intensity among U.S. adults: National Health and Nutrition Examination Survey 2011-2014. Med Sci Sports Exerc. Published online April 20, 2026. doi:10.1249/MSS.0000000000004009
Buszkiewicz JH, Vander Woude CA, Xie Y, et al. Associations between county-level e-cigarette-inclusive Tobacco 21 law population coverage and e-cigarette use behaviors among United States adolescents in Monitoring the Future. Addiction. 2026;121(4):982-993. doi:10.1111/add.70266
Greene NK, Seidenberg AB, Butera G, et al. Alcohol and cancer messaging: a scoping review. Cancer Epidemiol Biomarkers Prev. Published online March 31, 2026. doi:10.1158/1055-9965.EPI-25-2058
McClure EA, Baker N, Tomko RL, et al. Determining the impact of cannabis use on tobacco cessation: Results from a prospective non-randomized tobacco treatment trial. Addiction. Published online March 12, 2026. doi:10.1111/add.70382
Skiba MB, Contreras J 2nd, Nelson MA, et al. A pilot feasibility study of a group-based remote-delivered dyadic exercise intervention in hispanic men with prostate cancer and their caregivers. Cancer Med. 2026;15(3):e71709. doi:10.1002/cam4.71709
Parmet T, Li Y, Cappella J, Scherer LD, Waters EA, Housten AJ. Media reporting of the 2024 US Preventive Services Task Force Mammography Guideline Update. JAMA Netw Open. 2026;9(3):e260040. Published 2026 Mar 2. doi:10.1001/jamanetworkopen.2026.0040
Dhungel B, Borland R, Yong HH, et al. Trends in noticing and responding to, health warning labels on cigarette packages among adults who smoke: findings from the ITC Four Country Surveys between 2002 and 2022. Nicotine Tob Res. 2026;28(3):464-473. doi:10.1093/ntr/ntaf156
Irwin MR, Olmstead R, Chen L, Haque R. Insomnia and elevated risk of major depressive disorder in older adult, long-term breast cancer survivors vs a matched cohort. Sleep. 2026;49(2):zsaf322. doi:10.1093/sleep/zsaf322
Giovenco DP, Spillane TE, Lee HM, et al. Retail availability of oral nicotine pouches in three US cities: a geographic analysis. Nicotine Tob Res. 2026;28(2):230-236. doi:10.1093/ntr/ntae312
Peraza N, Han DH, Whaley RC, et al. Appeal and sensory characteristics of oral nicotine products in young adults who vape e-cigarettes. Nicotine Tob Res. 2026;28(2):204-212. doi:10.1093/ntr/ntae281
Hardin A, Ahn S, Ma S, et al. The association between product attributes and oral nicotine pouch preference-evidence from online stores. Nicotine Tob Res. 2026;28(2):298-303. doi:10.1093/ntr/ntaf137
Shams-White MM, Faust EJ, Zimmer M, et al. Diet, physical activity, and sleep assessment: a portfolio scoping review of measures in NIH-funded epidemiologic studies. AJPM Focus. 2025;5(1):100454. Published 2025 Sep 30. doi:10.1016/j.focus.2025.100454
Fladeboe KM, Fredman G, Maurer SH, et al. Feasibility and proof-of-concept of a combined resilience and social connection intervention for adolescents and young adults with cancer: a pilot randomized trial protocol. Pilot Feasibility Stud. 2026;12(1):32. Published 2026 Jan 29. doi:10.1186/s40814-026-01775-0
Tran K, Siegel LN, Smagulova M, Huang GC, Frauenholz M, Kirshner L, D'Angelo H, Czajkowski S, Tonorezos E, Land SR. Tobacco cessation services for cancer survivors: a capture and coding of U.S. National Cancer Institute (NCI)-Designated Cancer Center webpages. Nicotine Tob Res. 2026 Apr 24:ntag093. doi: 10.1093/ntr/ntag093. Epub ahead of print. PMID: 42028966.